Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · April 09, 2021

Combination of CD19 and CD22 CAR T-Cell Therapy in Relapsed B-Cell ALL After Allogeneic Transplantation

American Journal of Hematology


Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Hematology
Combination of CD19 and CD22 CAR-T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia After Allogeneic Transplantation
Am. J. Hematol 2021 Mar 16;[EPub Ahead of Print], S Liu, B Deng, Z Yin, Y Lin, L An, D Liu, J Pan, X Yu, B Chen, T Wu, AH Chang, C Tong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading